Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model

Stefano Molica; Diana Giannarelli; Andrea Visentin; Gianluigi Reda; Paolo Sportoletti; Anna Maria Frustaci; Annalisa Chiarenza; Stefania Ciolli; Candida Vitale; Luca Laurenti; Lorenzo De Paoli; Roberta Murru; Massimo Gentile; Riccardo Moia; Gian Matteo Rigolin; Luciano Levato; Annamaria Giordano; Giovanni Del Poeta; Caterina Stelitano; Marina Deodato; Claudia Ielo; Alessandro Noto; Valerio Guarente; Marta Coscia; Alessandra Tedeschi; Gianluca Gaidano; Antonio Cuneo; Robin Foa'; Robin Foa; Livio Trentin; Francesca Romana Mauro

doi:10.1002/ajh.26502

Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model

Stefano Molica
, Diana Giannarelli
, Andrea Visentin
, Gianluigi Reda
, Paolo Sportoletti
, Anna Maria Frustaci
, Annalisa Chiarenza
, Stefania Ciolli
, Candida Vitale
, Luca Laurenti
, Lorenzo De Paoli
, Roberta Murru
, Massimo Gentile
, Riccardo Moia
, Gian Matteo Rigolin
, Luciano Levato
, Annamaria Giordano
, Giovanni Del Poeta
, Caterina Stelitano
, Marina Deodato

Claudia Ielo, Alessandro Noto, Valerio Guarente, Marta Coscia, Alessandra Tedeschi, Gianluca Gaidano, Antonio Cuneo, Robin Foa', Robin Foa, Livio Trentin, Francesca Romana Mauro

Azienda Ospedaliera Pugliese-Ciaccio
University of Padua
IRCCS Fondazione Ca'Granda – Ospedale Maggiore Policlinico - Milano
University of Perugia
Asst Grande Ospedale Metropolitano Niguarda
Ferrarotto Hospital
Azienda Ospedaliera Careggi
University of Turin
University of Eastern Piedmont
AO Brotzu
Hematology Unit
Sant'Anna University Hospital of Ferrara
University of Bari
University of Rome Tor Vergata
Bianchi Melacrino Morelli
University “La Sapienza” of Rome

Risultato della ricerca: Contributo in rivista › Articolo

Abstract

NA

Lingua originale	Inglese
pagine (da-a)	E176-E180
Rivista	American Journal of Hematology
Volume	97
DOI	https://doi.org/10.1002/ajh.26502
Stato di pubblicazione	Pubblicato - 2022

Keywords

inglese

Accesso al documento

10.1002/ajh.26502

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

Molica, S., Giannarelli, D., Visentin, A., Reda, G., Sportoletti, P., Frustaci, A. M., Chiarenza, A., Ciolli, S., Vitale, C., Laurenti, L., De Paoli, L., Murru, R., Gentile, M., Moia, R., Rigolin, G. M., Levato, L., Giordano, A., Del Poeta, G., Stelitano, C., ... Mauro, F. R. (2022). Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model. American Journal of Hematology, 97, E176-E180. https://doi.org/10.1002/ajh.26502

@article{66a1a524a6924934b811b3bc86d60f2c,

title = "Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model",

abstract = "NA",

keywords = "inglese, inglese",

author = "Stefano Molica and Diana Giannarelli and Andrea Visentin and Gianluigi Reda and Paolo Sportoletti and Frustaci, \{Anna Maria\} and Annalisa Chiarenza and Stefania Ciolli and Candida Vitale and Luca Laurenti and \{De Paoli\}, Lorenzo and Roberta Murru and Massimo Gentile and Riccardo Moia and Rigolin, \{Gian Matteo\} and Luciano Levato and Annamaria Giordano and \{Del Poeta\}, Giovanni and Caterina Stelitano and Marina Deodato and Claudia Ielo and Alessandro Noto and Valerio Guarente and Marta Coscia and Alessandra Tedeschi and Gianluca Gaidano and Antonio Cuneo and Robin Foa' and Robin Foa and Livio Trentin and Mauro, \{Francesca Romana\}",

year = "2022",

doi = "10.1002/ajh.26502",

language = "English",

volume = "97",

pages = "E176--E180",

journal = "American Journal of Hematology",

issn = "1096-8652",

publisher = "John Wiley and Sons Inc.",

}

Molica, S, Giannarelli, D, Visentin, A, Reda, G, Sportoletti, P, Frustaci, AM, Chiarenza, A, Ciolli, S, Vitale, C, Laurenti, L, De Paoli, L, Murru, R, Gentile, M, Moia, R, Rigolin, GM, Levato, L, Giordano, A, Del Poeta, G, Stelitano, C, Deodato, M, Ielo, C, Noto, A, Guarente, V, Coscia, M, Tedeschi, A, Gaidano, G, Cuneo, A, Foa', R, Foa, R, Trentin, L & Mauro, FR 2022, 'Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model', American Journal of Hematology, vol. 97, pagg. E176-E180. https://doi.org/10.1002/ajh.26502

TY - JOUR

T1 - Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model

AU - Molica, Stefano

AU - Giannarelli, Diana

AU - Visentin, Andrea

AU - Reda, Gianluigi

AU - Sportoletti, Paolo

AU - Frustaci, Anna Maria

AU - Chiarenza, Annalisa

AU - Ciolli, Stefania

AU - Vitale, Candida

AU - Laurenti, Luca

AU - De Paoli, Lorenzo

AU - Murru, Roberta

AU - Gentile, Massimo

AU - Moia, Riccardo

AU - Rigolin, Gian Matteo

AU - Levato, Luciano

AU - Giordano, Annamaria

AU - Del Poeta, Giovanni

AU - Stelitano, Caterina

AU - Deodato, Marina

AU - Ielo, Claudia

AU - Noto, Alessandro

AU - Guarente, Valerio

AU - Coscia, Marta

AU - Tedeschi, Alessandra

AU - Gaidano, Gianluca

AU - Cuneo, Antonio

AU - Foa', Robin

AU - Foa, Robin

AU - Trentin, Livio

AU - Mauro, Francesca Romana

PY - 2022

Y1 - 2022

N2 - NA

AB - NA

KW - inglese

UR - http://hdl.handle.net/10807/235493

U2 - 10.1002/ajh.26502

DO - 10.1002/ajh.26502

M3 - Article

SN - 1096-8652

VL - 97

SP - E176-E180

JO - American Journal of Hematology

JF - American Journal of Hematology

ER -

Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo